Jenkins M - Search Results

1

Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.

Lovelock PK, Healey S, Au W, Sum EY, Tesoriero A, Wong EM, Hinson S, Brinkworth R, Bekessy A, Diez O, Izatt L, Solomon E, Jenkins M, Renard H, Hopper J, Waring P, Tavtigian SV, Goldgar D, Lindeman GJ, Visvader JE, Couch FJ, Henderson BR, Southey M, Chenevix-Trench G, Spurdle AB, Brown MA; kConFab Investigators. Lovelock PK, et al. Among authors: jenkins m. J Med Genet. 2006 Jan;43(1):74-83. doi: 10.1136/jmg.2005.033258. Epub 2005 May 27. J Med Genet. 2006. PMID: 15923272 Free PMC article.

2

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics.

Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL. Scott CL, et al. Hum Genet. 2003 May;112(5-6):542-51. doi: 10.1007/s00439-003-0908-6. Epub 2003 Feb 25. Hum Genet. 2003. PMID: 12601471

3

Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.

Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA, Giles GG, Hopper JL, Dobrovic A. Wong EM, et al. Cancer Prev Res (Phila). 2011 Jan;4(1):23-33. doi: 10.1158/1940-6207.CAPR-10-0212. Epub 2010 Oct 26. Cancer Prev Res (Phila). 2011. PMID: 20978112 Free PMC article.

4

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.

Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC; kConFab Investigators; Ontario Cancer Genetics Network Investigators; Whittemore AS. Haile RW, et al. Among authors: jenkins ma. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70. doi: 10.1158/1055-9965.EPI-06-0258. Epub 2006 Oct 4. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17021353

5

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women.

Dowty JG, Lose F, Jenkins MA, Chang JH, Chen X, Beesley J, Dite GS, Southey MC, Byrnes GB, Tesoriero A, Giles GG, Hopper JL, Spurdle AB; kConFab Investigators; Australian Breast Cancer Family Study (ABCFS). Dowty JG, et al. Breast Cancer Res Treat. 2008 Nov;112(1):35-9. doi: 10.1007/s10549-007-9832-0. Epub 2007 Dec 4. Breast Cancer Res Treat. 2008. PMID: 18058226

6

Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.

Arnold S, Buchanan DD, Barker M, Jaskowski L, Walsh MD, Birney G, Woods MO, Hopper JL, Jenkins MA, Brown MA, Tavtigian SV, Goldgar DE, Young JP, Spurdle AB. Arnold S, et al. Among authors: jenkins ma. Hum Mutat. 2009 May;30(5):757-70. doi: 10.1002/humu.20936. Hum Mutat. 2009. PMID: 19267393 Free PMC article.

7

Large genomic alterations in hMSH2 and hMLH1 in early-onset colorectal cancer: identification of a large complex de novo hMLH1 alteration.

Smith L, Tesoriero A, Mead L, Royce S, Grubb G, Young J, Giles G, Jenkins M, Macrae F, Hopper JL, Southey MC. Smith L, et al. Among authors: jenkins m. Clin Genet. 2006 Sep;70(3):250-2. doi: 10.1111/j.1399-0004.2006.00662.x. Clin Genet. 2006. PMID: 16922729 No abstract available.

8

Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer.

Jenkins MA, Southey MC, Giles GG, Hopper JL. Jenkins MA, et al. Curr Oncol Rep. 2007 May;9(3):202-7. doi: 10.1007/s11912-007-0022-3. Curr Oncol Rep. 2007. PMID: 17430691 Review.

9

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Dite GS, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):448-57. doi: 10.1093/jnci/95.6.448. J Natl Cancer Inst. 2003. PMID: 12644538

10

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.

Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB. Chang JH, et al. Among authors: jenkins ma. Breast Cancer Res. 2005;7(4):R513-21. doi: 10.1186/bcr1040. Epub 2005 May 12. Breast Cancer Res. 2005. PMID: 15987458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,484 results

Search Page